Abselion has expanded its Amperia™ platform with a Tagged Protein Quantification Kit | His-tag and a Tagged Protein Sensor | ...

CAMBRIDGE, England--(BUSINESS WIRE)--Abselion, a pioneering life sciences technology company focused on simplifying biomolecule quantification, has expanded its Amperia™ assay portfolio with the ...

Protein quantification is critical in biologics research and development. However, current methods such as ELISA, BLI, and SPR have complex workflows and can struggle with crude samples or early-stage ...

The company highlights how its technology powers large-scale proteomic perturbation studies, unveiling Perturb-PBMC, a 1.4 million–protein PBMC dataset available in the Nomic Portal Nomic Bio (“Nomic” ...

Protein detection sensitivity has historically lagged behind nucleic acid detection by 2-3 orders of magnitude due to the lack of intrinsic signal amplification. While digital methods such as Single ...

As gene therapies continue to advance, the demand for scalable, reproducible, and efficient potency assays is rapidly increasing—especially for adeno-associated virus (AAV) vectors. Accurate ...

The last two weeks have been packed with collaborations for unveiling innovative products and kick-starting prosperous partnerships. From quantifying His-tagged proteins and characterizing mutations ...

Ready-to-use solution, developed in collaboration with GenScript, offers rapid and reliable quantification of His-tagged proteins Broadens Amperia’s applications across recombinant protein research, ...

Abselion has launched the His-Tagged Protein Quantification Kit for use with its Amperia™ benchtop platform. Developed with GenScript’s THE™ His Tag Monoclonal Antibodies, the kit enables rapid ...